Meeting
2022 ASCO Annual Meeting
Increasing the use of olanzapine in patients receiving chemotherapy in a community oncology practice.
Authors
Bindu Rani Potugari
Saint Joseph Mercy Health System, Ann Arbor, MI
Bindu Rani Potugari , Kathleen W. Beekman , Jane Tolkinen , Jennifer J. Griggs
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 12123)
DOI
10.1200/JCO.2022.40.16_suppl.12123
Abstract #
12123
Poster Bd #
367
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Outcomes of clinical pharmacist integration in a community oncology practice.
First Author: Katie Sias
Poster
2023 ASCO Annual Meeting
Guideline-concordant use of olanzapine as part of a 4-drug antiemetic regimen for high emetic risk chemotherapy across the state of Michigan.
First Author: Ashley Bowen
Poster
2022 ASCO Quality Care Symposium
Patterns of olanzapine prescribing for those receiving highly emetogenic chemotherapy.
First Author: Daniel S Childs
Poster
2022 ASCO Quality Care Symposium
EpiPen STAT: A quality improvement project for anaphylaxis management.
First Author: Aya Sato-DiLorenzo